India Pesticides Limited Q4 FY23
Results in line with expectations.
Revenue up 23% YoY for FY23
EBITDA margin at 22% vs 30% YOY for full year.
Highlights from Q4 concall
In advance talk for collaboration with Japan based Pharma company for API
Received registration for Thiocarbamate product in US. Expecting 50cr sales.
Headwinds continues globally. High cost inventory is still a concern for next 1-2 quarters.
110cr capex planned for FY24
Will be able to maintain current EBITDA margins of 21% and improve from here on in next 2-3 quarters.
| Subscribe To Our Free Newsletter |
